Are you using real-world evidence?
Parexel’s experts offer a roadmap and best practices for current RWE applications across three development arenas:
- Early asset planning
- Clinical development: Meeting regulatory expectations
- Medical marketplace: Demonstrating value in the real world
In each section of this playbook, we highlight examples of recent Parexel projects that illustrate the power of RWE to improve decision-making and to drive cost- and times-saving development strategies.
Related Insights
Playbook
Streamlining success: How integrated evidence planning transforms asset development
Feb 27, 2025
Blog
Beyond participation: How EU HTA is turning patient and clinician engagement into evidence architecture
May 26, 2026
Webinar
Investor-ready strategy: Integrated evidence planning to maximize commercial opportunity
Sep 17, 2025
Blog
Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress
May 2, 2024
Blog
Regulatory acceptability of AI: Current perspectives
Mar 7, 2024
Article
Near-term strategies for biotech drug developers facing shifting healthcare dynamics
Feb 14, 2024
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Whitepaper
The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations
Mar 9, 2023
Podcast
RBQM Podcast Series | Episode 3: Staying within the Guardrails: How to Push the Boundaries in a Highly Regulated Industry
Jun 16, 2022
Related Insights
Playbook
Streamlining success: How integrated evidence planning transforms asset development
Feb 27, 2025
Blog
Beyond participation: How EU HTA is turning patient and clinician engagement into evidence architecture
May 26, 2026
Webinar
Investor-ready strategy: Integrated evidence planning to maximize commercial opportunity
Sep 17, 2025
Blog
Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress
May 2, 2024
Blog
Regulatory acceptability of AI: Current perspectives
Mar 7, 2024
Article
Near-term strategies for biotech drug developers facing shifting healthcare dynamics
Feb 14, 2024
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Whitepaper
The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations
Mar 9, 2023
Podcast
RBQM Podcast Series | Episode 3: Staying within the Guardrails: How to Push the Boundaries in a Highly Regulated Industry
Jun 16, 2022